Recent Events & Catalysts
Insmed Incorporated (INSM) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
American Century Focused Dynamic Growth Fund Q2 2026 Portfolio Review
SeekingAlpha · today
JP Morgan Maintains Overweight on Insmed, Lowers Price Target to $175
Benzinga · 1d ago
Truist Securities Reiterates Buy on Insmed, Raises Price Target to $195
Benzinga · 1d ago
$1000 Invested In Insmed 5 Years Ago Would Be Worth This Much Today
Benzinga · 1d ago
HQH: After Biotech's Breakout Year, This Healthcare CEF Still Trades Below NAV; Buy
SeekingAlpha · 4d ago
Guggenheim Maintains Buy on Insmed, Lowers Price Target to $205
Benzinga · 4d ago
Wells Fargo Maintains Overweight on Insmed, Raises Price Target to $169
Benzinga · 4d ago
Evercore ISI Group Maintains Outperform on Insmed, Raises Price Target to $170
Benzinga · 4d ago
SEC Filings (90 days)
Results of operations (earnings release), Financial statements and exhibits
Filed 2026-08-06 · 5d ago · Material
Regulation FD disclosure, Financial statements and exhibits
Filed 2026-07-16 · 26d ago
Submission of matters to a vote of security holders
Filed 2026-05-15 · 88d ago
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.